Freedom Investment Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-4,663
Closed -$295K 602
2020
Q1
$295K Buy
+4,663
New +$269K 0.03% 505
2019
Q3
Sell
-6,648
Closed -$335K 705
2019
Q2
$335K Buy
+6,648
New +$323K 0.03% 487
2019
Q1
Sell
-4,284
Closed -$210K 716
2018
Q4
$210K Sell
4,284
-1,890
-31% -$107K 0.02% 691
2018
Q3
$400K Sell
6,174
-10,366
-63% -$630K 0.03% 615
2018
Q2
$891K Buy
16,540
+8,336
+102% +$417K 0.05% 366
2018
Q1
$373K Sell
8,204
-2,903
-26% -$124K 0.02% 796
2017
Q4
$437K Sell
11,107
-1,620
-13% -$61.6K 0.02% 694
2017
Q3
$469K Buy
+12,727
New +$453K 0.03% 625
2017
Q2
Sell
-9,368
Closed -$319K 1075
2017
Q1
$319K Buy
+9,368
New +$308K 0.02% 732

Other funds holding EHC

Freedom Investment Management's EHC Position: Q2 2020 in Review

Freedom Investment Management sold out of Encompass Health (EHC) in Q2 2020, closing a stake of 4,663 shares — an estimated $295K sold.

Freedom Investment Management first reported a position in EHC in Q1 2017 and held it in 9 quarters. The position peaked at $891K in Q2 2018. 384 funds tracked by Wall St. Rank hold EHC as of Q2 2020.

  • Freedom Investment Management reported no remaining Encompass Health position as of Q2 2020 after selling out during the quarter.
  • Freedom Investment Management sold 4,663 Encompass Health shares in Q2 2020, an estimated $295K.
  • Freedom Investment Management first reported a position in Encompass Health in Q1 2017 and held it in 9 quarters.
  • Freedom Investment Management's Encompass Health position peaked at $891K in Q2 2018.
  • 384 funds tracked by Wall St. Rank held Encompass Health as of Q2 2020.

Based on Freedom Investment Management's 13F filing for Q2 2020, filed 10 Aug 2020.